GlassScriptPhysician profile
Scott R Anderson
NPI 1841467362
$5,507.13
in general payments reported to CMS, 2019-2025
24 companies · $1,147 in 2025
The $1,147 reported for 2025 was more than what 82% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $779 · 2020: $178 · 2021: $1,088 · 2022: $294 · 2023: $891 · 2024: $1,131 · 2025: $1,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,071 · Education: $98.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,071.38 |
| Education | $98.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $980.31 | 2019-2025 | Dupixent |
| Genzyme Corporation | $899.83 | 2019-2025 | |
| Medtronic, INC. | $733.26 | 2021-2025 | Stealthstation S8 Platform, Propel, Nuvent |
| Optinose US, INC. | $697.47 | 2019-2025 | |
| Acclarent, INC | $443.92 | 2019-2024 | Trudi Nav Cable, Relieva Spinplus |
| Glaxosmithkline, LLC. | $420.04 | 2019-2025 | Nucala |
| Intersect Ent, INC. | $215.40 | 2019-2021 | |
| Medtronic USA, INC. | $215.38 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $165.90 | 2019-2025 | Tezspire |
| Neurent Medical Limited | $165.78 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Kaleo, INC. | $77.91 | 2019-2023 | Auvi-Q |
| Hikma Pharmaceuticals USA | $71.28 | 2023-2024 | Ryaltris |
| Aerin Medical INC. | $68.76 | 2022-2025 | |
| Stryker Corporation | $66.49 | 2019 | |
| Karl Storz Endoscopy-America | $57.52 | 2022-2025 | Image1 S Connect |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $53.01 | 2021-2025 | |
| Amgen INC. | $47.60 | 2023-2025 | Tavneos, Tezspire |
| Itamar Medical INC | $31.71 | 2025 | Watchpatone |
| Integra Lifesciences Corporation | $18.36 | 2024 | Integra, Integra Duo, Instruments-Orthopedic |
| Genentech USA, INC. | $16.87 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $16.44 | 2025 | Neffy |
| Smith+Nephew, INC. | $16.19 | 2020 | |
| Phadia US INC. | $14.95 | 2024 | Immunocap |
| Alk-Abello, INC | $12.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.